Medication Diversion Investigation

Use it as soon as a suspected diversion, unexplained count variance, or documentation mismatch is identified. It is designed for the investigation phase, not routine medication administration. If the issue involves a controlled substance, start containment and preserve records before the review continues. The template helps you document what was found, who was interviewed, and what follow-up was completed.

It is primarily built for suspected controlled-substance diversion, where count reconciliation, witness verification, and chain-of-custody are central. You can adapt it for other high-risk medications if your policy requires similar documentation, but the core workflow assumes a discrepancy in a secured medication process. For non-controlled meds, some count and witness fields may not be relevant. Keep the scope aligned to your facility policy and state requirements.

A nurse manager, director of nursing, compliance lead, pharmacy lead, or other designated investigator should complete it, depending on your policy. The person documenting the case should be separate from the staff member under review whenever possible. Witnesses and direct supervisors may contribute statements, but the final record should show who owned each action. Clear ownership matters because diversion cases often involve multiple departments.

It is used on an as-needed basis whenever a discrepancy, missing dose, unexplained waste, or suspicious access pattern triggers an investigation. It is not a scheduled audit form, although facilities may use it alongside periodic controlled-substance audits. If your organization has recurring issues, you can also use it to standardize trend reviews over time. The template is meant to capture one case from intake through closure.

This template supports internal compliance programs and documentation practices commonly expected in healthcare settings, including controlled-substance accountability, pharmacy oversight, and incident reporting. It can help align with state board of nursing expectations, DEA-related controlled-substance controls where applicable, and facility policies for medication security. It also supports accreditation and quality review by creating a clear case record. Always follow your organization’s legal and regulatory reporting rules for the jurisdiction involved.

Common mistakes include documenting only the missing dose without reconciling the full count history, failing to note who witnessed the count, and leaving interview statements too vague to support follow-up. Another frequent issue is not recording the exact time the discrepancy was discovered and what containment steps were taken. Investigations also get weakened when pharmacy is not notified promptly or when corrective actions have no owner and due date. This template is built to prevent those gaps.

Yes. The same structure works across hospitals, skilled nursing, assisted living, and other care settings, but you should tailor the medication storage, count frequency, and witness rules to the environment. For example, a long-term care facility may emphasize shift-to-shift counts, while a hospital may add automated dispensing cabinet access review. Home health use would usually require a different chain-of-custody and storage approach. Keep the sections that match your workflow and remove those that do not.

An ad hoc note usually captures only fragments of the event and makes it hard to prove what was checked, who confirmed it, and what action followed. This template creates a consistent investigation record with MAR review, count reconciliation, witness verification, interviews, and pharmacy follow-up in one place. That structure makes it easier to close the loop and support internal review later. It also reduces the risk of missing a required reporting step.